Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancerTarek M. Abdel-Fatah, Srinivasan Madhusudan, Roslin Russell et al.|Molecular Oncology|2014Cited by 151
Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settingsT. M. A. Abdel-Fatah, Stephen Chan, Christina J. Perry et al.|Annals of Oncology|2013Cited by 88
Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer CellsRebeka Sultana, Srinivasan Madhusudan, Tarek M.A. Abdel-Fatah et al.|PLoS ONE|2013Cited by 85
Untangling the ATR‐CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancerTarek M.A. Abdel-Fatah, Srinivasan Madhusudan, Fiona K. Middleton et al.|Molecular Oncology|2014Cited by 84
Targeting BRCA1‐BER deficient breast cancer by ATM or DNA‐PKcs blockade either alone or in combination with cisplatin for personalized therapyNada Albarakati, Srinivasan Madhusudan, Arvind Arora et al.|Molecular Oncology|2014Cited by 80